Keyphrases
Activation Markers
16%
Allogeneic
16%
Anti-CD3/CD28
16%
Apoptosis
16%
Body Mass Index
16%
CD25
16%
CD274
33%
CD4 T Cells
100%
CD4+
16%
CD54
33%
CD69 Expression
16%
Cell Culture
16%
Cell-based
16%
Conditioned Medium
16%
Cytokine Expression
16%
Donor Characteristics
16%
Flow Cytometry
16%
FoxP3+
16%
HLA-DR Expression
16%
IL-2 Production
16%
Immunomodulator
33%
Immunomodulatory Activity
100%
Immunomodulatory Therapy
16%
Indoleamine 2,3-dioxygenase 1 (IDO1)
33%
Inflammatory Conditions
33%
Inflammatory Environment
16%
Inhibitory Effect
16%
Interferon-γ Production
16%
Interleukin-17 (IL-17)
16%
Interleukin-6
16%
Interleukin-8
16%
Intracellular Cytokines
16%
Mesenchymal Stromal Cells
100%
No Significant Difference
16%
Non-diabetic
16%
Normal Weight
16%
Obesity
100%
Prostaglandin E2
16%
Regulatory T Cells
16%
Stem Cell-derived
100%
Stromal Stem Cells
83%
Surface Expression
16%
T Cell Subsets
16%
Treg
33%
Type 2 Diabetes Mellitus (T2DM)
100%
Immunology and Microbiology
Adipose Tissue
100%
Body Mass
14%
CD25
14%
CD28
14%
CD3 Antigen
14%
CD4
14%
CD69
14%
Cell Viability
14%
Coculture
42%
Cytokine
28%
ELISA
14%
FOXP3
14%
HLA-DR
14%
Immunomodulating Drugs
28%
Indoleamine 2,3-dioxygenase
28%
Interferon Gamma
14%
Interleukin 2
14%
Interleukin 6
14%
Interleukin 8
14%
Programmed Cell Death
14%
Prostaglandin E2
14%
Regulatory T Cell
42%
Stem Cell
100%
T Cell Proliferation
14%
T Cell Subset
14%
T-Helper Cell
100%
Medicine and Dentistry
Adipose Tissue
100%
Body Mass Index
14%
CD3 Antigen
14%
Cell Viability
14%
Cytokine
28%
Enzyme Linked Immunosorbent Assay
14%
Flow Cytometry
14%
Gamma Interferon
14%
Immunomodulating Agent
28%
Indoleamine 2,3 Dioxygenase
28%
Interleukin 2
14%
Interleukin 6
14%
Maturity Onset Diabetes of the Young
100%
Programmed Cell Death
14%
Prostaglandin E2
14%
Regulatory T Cell
14%
Serositis
28%
Stem Cell
100%
T Cell Proliferation
14%
T Cell Subset
14%
T-Helper Cell
100%